Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA068465-01A1
Application #
2112436
Study Section
Experimental Immunology Study Section (EI)
Project Start
1996-05-15
Project End
1999-04-30
Budget Start
1996-05-15
Budget End
1997-04-30
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Balko, Justin M; Schwarz, Luis J; Bhola, Neil E et al. (2013) Activation of MAPK pathways due to DUSP4 loss promotes cancer stem cell-like phenotypes in basal-like breast cancer. Cancer Res 73:6346-58
Thomas, Lance R; Tansey, William P (2011) Proteolytic control of the oncoprotein transcription factor Myc. Adv Cancer Res 110:77-106
Simpson, David R; Yu, Min; Zheng, Siyuan et al. (2011) Epithelial cell organization suppresses Myc function by attenuating Myc expression. Cancer Res 71:3822-30
Samaras, Susan E; Cissell, Michelle A; Gerrish, Kevin et al. (2002) Conserved sequences in a tissue-specific regulatory region of the pdx-1 gene mediate transcription in Pancreatic beta cells: role for hepatocyte nuclear factor 3 beta and Pax6. Mol Cell Biol 22:4702-13
Penichet, M L; Morrison, S L (2001) Antibody-cytokine fusion proteins for the therapy of cancer. J Immunol Methods 248:91-101
Fingleton, B; Matrisian, L M (2001) Matrix metalloproteinases as targets for therapy in Kaposi sarcoma. Curr Opin Oncol 13:368-73
Wang, L; Hiebert, S W (2001) TEL contacts multiple co-repressors and specifically associates with histone deacetylase-3. Oncogene 20:3716-25
Fenrick, R; Wang, L; Nip, J et al. (2000) TEL, a putative tumor suppressor, modulates cell growth and cell morphology of ras-transformed cells while repressing the transcription of stromelysin-1. Mol Cell Biol 20:5828-39
Peng, L S; Penichet, M L; Morrison, S L (1999) A single-chain IL-12 IgG3 antibody fusion protein retains antibody specificity and IL-12 bioactivity and demonstrates antitumor activity. J Immunol 163:250-8
Penichet, M L; Challita, P M; Shin, S U et al. (1999) In vivo properties of three human HER2/neu-expressing murine cell lines in immunocompetent mice. Lab Anim Sci 49:179-88

Showing the most recent 10 out of 15 publications